Inva3b1 Mouse

Disease model for psoriasis; in vivo study of human alpha3 and beta1 integrin transgene expression in skin.

Contributors

Inventor Institute
Fiona Watt Cancer Research UK, London Research Institute: Lincoln's Inn Fields
Cat. #: 151549
Research Fields: Cell biology;Genetics
Target: Alpha3 intergrin, beta1 integrin
disease: Psoriasis
Zygosity: Heterozygous
Phenotype: Mice present phenotype very similar to human psoriasis disease.
Product description: Disease model for psoriasis; in vivo study of human alpha3 and beta1 integrin transgene expression in skin.
Conditional: Yes
Conditional description: Conditional expression of integrins under involucrin promoter giving tissue-specific suprabasal epidermal expression.
Genetic background: Involucrin – integrin transgene expression constructs were injected into fertilized oocytes from F1 hybrid CBAxC57Bl/6 mice. Transgene-positive mice were back-crossed to generate individual founder lines. alpha3 founder line was crossed with beta1 founder line to generate alpha3beta1 line.
Production details: Involucrin – integrin transgene expression constructs were injected into fertilized oocytes from F1 hybrid CBAxC57Bl/6 mice. Transgene-positive mice were back-crossed to generate individual founder lines. alpha3 founder line was crossed with beta1 founder line to generate alpha3beta1 line.
Additional notes: Mice present phenotype very similar to human psoriasis disease.
Shipping conditions: Embryo/Spermatoza- Dry Ice
References:

Carroll et al. 1995. Cell. 83(6):957-68. PMID: 8521519.

Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis.

Related Tools for Mouse models

Cat. # Tool Name
151467 p23+/- Mouse Key Info View Tool
151475 Raf KI D486A Mouse Key Info View Tool
151518 Lupus Mouse Key Info View Tool
151519 BRaf1 KI Mouse Key Info View Tool
151555 MUC1 Mouse Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.